U.S. Cell Counting Market Size & Outlook, 2022-2030
U.S. cell counting market, 2018-2030 (US$M)
Related Markets
U.S. cell counting market highlights
- The U.S. cell counting market generated a revenue of USD 2,792.5 million in 2022 and is expected to reach USD 4,786.5 million by 2030.
- The U.S. market is expected to grow at a CAGR of 7% from 2023 to 2030.
- In terms of segment, instruments was the largest revenue generating product in 2022.
- Consumables & Accessories is the most lucrative product segment registering the fastest growth during the forecast period.
Cell counting market data book summary
| Market revenue in 2022 | USD 2,792.5 million |
| Market revenue in 2030 | USD 4,786.5 million |
| Growth rate | 7% (CAGR from 2022 to 2030) |
| Largest segment | Instruments |
| Fastest growing segment | Consumables & Accessories |
| Historical data | 2018 - 2021 |
| Base year | 2022 |
| Forecast period | 2023 - 2030 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Instruments, Consumables & Accessories |
| Key market players worldwide | Thermo Fisher Scientific Inc, Merck KGaA, Agilent Technologies, PerkinElmer, BD, Danaher Corp, Bio-Rad Laboratories Inc, Biotek, GE HealthCare Technologies Inc Common Stock |
Other key industry trends
- In terms of revenue, U.S. accounted for 33.9% of the global cell counting market in 2022.
- Country-wise, U.S. is expected to lead the global market in terms of revenue in 2030.
- In North America, U.S. cell counting market is projected to lead the regional market in terms of revenue in 2030.
- Canada is the fastest growing regional market in North America and is projected to reach USD 590.9 million by 2030.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Cell Counting Market Scope
Cell Counting Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|
U.S. cell counting market outlook
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to cell counting market will help companies and investors design strategic landscapes.
Instruments was the largest segment with a revenue share of 50.11% in 2022. Horizon Databook has segmented the U.S. cell counting market based on instruments, consumables & accessories covering the revenue growth of each sub-segment from 2018 to 2030.
Increasing focus on biomedical, stem cells, and cancer research is a key factor contributing toward its high market share. The rising prevalence of chronic diseases such as cardiovascular & blood diseases is expected to fuel market growth.
There is increasing focus on cancer research and stem cell research activities. Stem cell therapy is the most promising technique to treat severe medical conditions including cancer and blood diseases.
Thus, biotechnology and biopharmaceutical companies are adopting advanced cell counting products such as magnetic beads for the research & development of stem cells, which is projected to drive the market growth.
Reasons to subscribe to U.S. cell counting market databook:
-
Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
-
Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
-
Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
-
Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
-
Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of U.S. cell counting market databook
-
Our clientele includes a mix of cell counting market companies, investment firms, advisory firms & academic institutions.
-
30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
-
Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
-
The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of country-level data and insights on the U.S. cell counting market, including forecasts for subscribers. This country databook contains high-level insights into U.S. cell counting market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Partial client list
U.S. cell counting market size, by product, 2018-2030 (US$M)
U.S. Cell Counting Market Share, 2022 & 2030 (US$M)
Related industry reports
Related regional statistics
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
